| Net Cash Provided by (Used in) Operating Activities |
$314,321,000 |
USD |
-1743% |
Q1 2024 |
Q1 2024 |
| Net Cash Provided by (Used in) Financing Activities |
$313,102,000 |
USD |
40563% |
Q1 2024 |
Q1 2024 |
| Common Stock, Shares Authorized |
500,000,000 |
shares |
0% |
Q3 2024 |
Q3 2024 |
| Common Stock, Shares, Issued |
123,356,823 |
shares |
0.67% |
Q3 2024 |
Q3 2024 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$1,219,000 |
USD |
-106% |
Q1 2024 |
Q1 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$151,341,000 |
USD |
96% |
Q3 2024 |
Q3 2024 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$30,222,000 |
USD |
5.4% |
Q1 2024 |
Q1 2024 |
| Additional Paid in Capital |
$1,837,067,000 |
USD |
0.57% |
Q3 2024 |
Q3 2024 |
| Interest Expense |
$159,298,000 |
USD |
39% |
Q3 2024 |
Q3 2024 |